[Herpes zoster in immunosuppressed patients with immuno-inflammatory disease].
We analysed 19 episodes of herpes zoster in 16 patients, who received cytotoxic drugs or cyclosporin for immuno-inflammatory disease. Reactivation of varicella-zoster virus was not associated with increased activity of the rheumatic disease nor with increased intensity of immunosuppressive therapy. Six of the patients who had received the largest cumulative doses of cytotoxic drugs had fever and/or vesicles outside the primarily affected dermatome. Two of these patients developed post-herpetic neuralgia. Although not encountered in this material, immunocompromised patients may develop severe complications of herpes zoster, and therefore prompt treatment with acyclovir is recommended in all cases. It is suggested that oral acyclovir therapy is sufficient in uncomplicated cases but this question has not been elucidated in controlled studies.
Schou
M
M
Andersen
V
V
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000276:immunology; D003240:Connective Tissue Diseases / Q000276:immunology*; D003524:Cyclosporins / Q000009:adverse effects; D005260:Female; D006562:Herpes Zoster / Q000209:etiology* / Q000276:immunology; D006801:Humans; D007249:Inflammation / Q000276:immunology; D008297:Male; D008875:Middle Aged
D000970:Antineoplastic Agents; D003524:Cyclosporins
Herpes zoster hos immunsupprimerede patienter med bindevaevsimmunsygdomme.